Anti-platelet Drug Blocks Bone Metastases In Mice; Treatment Also Slows Development Of Other Tumors

Researchers at Washington University School of Medicine in St. Louis have dramatically slowed the metastatic spread of a highly malignant tumor in mice by disabling platelets with an experimental drug. Based on earlier experiments, scientists had hoped the drug, ML464, would block the spread of a melanoma cell line into bones. They were pleasantly surprised to find that not only did the treatment block bone metastases, it also reduced the development of new tumors in organs like the liver, intestines and kidney.

Back to news